CANF
Can-fite Biopharma·AMEX
--
--(--)
--
--(--)
CANF Filings
Filing Date
Form Description
Form Type
2026-02-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-27
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-27 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-16
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-16 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-29 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-16
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-16 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-21
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-21 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-21
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-21 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
